Human Babesiosis.

Area of Science:

• Infectious Diseases
• Parasitology
• Public Health

Background:

• Babesiosis is a tick-borne zoonosis caused by intraerythrocytic parasites of the genus Babesia.
• Transmission occurs primarily through tick bites, with less common routes including blood transfusion, organ transplantation, and transplacental routes.
• The disease is geographically widespread but most prevalent in the Northeastern and upper Midwestern United States.

Purpose of the Study:

• To provide a comprehensive overview of babesiosis, covering its transmission, clinical presentation, diagnosis, and treatment.
• To highlight the epidemiological distribution and risk factors associated with human babesiosis.
• To emphasize the importance of timely diagnosis and appropriate management, particularly in vulnerable populations.

Main Methods:

• Review of existing literature on babesiosis epidemiology, clinical manifestations, and diagnostic modalities.
• Analysis of diagnostic techniques, including blood smear microscopy and polymerase chain reaction (PCR) for Babesia DNA detection.
• Summary of current standard treatment regimens.

Main Results:

• Babesiosis presents with malaria-like symptoms and can be severe or fatal in immunocompromised individuals and the elderly.
• Diagnosis relies on identifying Babesia parasites in blood smears or detecting parasite DNA via PCR.
• Standard treatment involves a 7-to-10-day course of atovaquone with azithromycin or clindamycin with quinine.

Conclusions:

• Babesiosis is a significant public health concern, particularly in specific regions of the United States.
• Accurate diagnosis through parasitological or molecular methods is essential for effective patient management.
• Prompt and appropriate antiparasitic treatment is critical for improving outcomes and preventing mortality.